CORSAIR CAPITAL MANAGEMENT, L.P.

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1276470 NEW YORK, NY

Back to AQST Full portfolio

Position in AQST

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$291,200

+$700 QoQ

Shares Held

70,000

0.0% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#70

of 185 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AQST Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CORSAIR CAPITAL MANAGEMENT, L.P. holds $2,321,580 across 4 Drug Manufacturers - Specialty & Generic names. AQST ranks #3 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	15,000	$1,195,950
2	HROW	Harrow, Inc.	19,000	$806,930
3	AQST	Aquestive Therapeutics, Inc. This page	70,000	$291,200
4	RMTI	Rockwell Medical, Inc.	5,000	$27,500

All Filings in AQST

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$291,200	70,000	0.0%	Shares	Sole	2026-08-14
2026-03-31	$290,500	70,000	+16.7%	Shares	Sole	2026-05-15
2025-12-31	$387,600	60,000	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.